Lucid Diagnostics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Lucid Diagnostics Inc
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Lucid Diagnostics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Lucid Diagnostics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Lucid Diagnostics Inc is LUCD:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Lucid Diagnostics Inc has its primary listing on NASDAQ. You can trade Lucid Diagnostics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Lucid Diagnostics Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Lucid Diagnostics Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Lucid Diagnostics Inc.